Patents by Inventor Charles A. Blum

Charles A. Blum has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040156869
    Abstract: 1 Certain 2-substituted quinazolin-4-ylamine analogues are provided. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
    Type: Application
    Filed: December 12, 2003
    Publication date: August 12, 2004
    Applicant: Neurogen Corporation
    Inventors: Rajagopal Bakthavatchalam, Charles A. Blum, Harry Brielmann, Timothy M. Caldwell, Stephane De Lombaert, Kevin J. Hodgetts, Xiaozhang Zheng
  • Publication number: 20040106616
    Abstract: Substituted quinazolin-4-ylamine analogues are provided. Such compounds are ligands that may be used to modulate specific receptor activity in vivo or in vitro, and are particularly useful in the treatment of conditions associated with pathological receptor activation in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for using them to treat such disorders are provided, as are methods for using such ligands for receptor localization studies.
    Type: Application
    Filed: January 21, 2003
    Publication date: June 3, 2004
    Inventors: Rajagopal Bakthavatchalam, Charles A. Blum, Harry Brielmann, Timothy M. Caldwell, Stephane De Lombaert, Kevin J. Hodgetts, Taeyoung Yoon, Xiaozhang Zheng
  • Publication number: 20040072847
    Abstract: Substituted spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
    Type: Application
    Filed: April 9, 2003
    Publication date: April 15, 2004
    Applicants: NEUROGEN CORPORATION, PFIZER INC.
    Inventors: Rajagopal Bakthavatchalam, Charles A. Blum, Harry L. Brielmann, James William Darrow, Stephane De Lombaert, Alan Hutchison, Jennifer Tran, Xiaozhang Zheng, Richard Louis Elliott, Marlys Hammond
  • Patent number: 6706669
    Abstract: The present invention relates to a method for inhibiting high temperature of corrosion-prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of phosphorous acid, typically up to 1000 wppm, to the metal surface.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: March 16, 2004
    Assignee: ExxonMobil Research and Engineering Company
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh, Andreas Vogel
  • Patent number: 6679987
    Abstract: The invention relates to processes for treating acidic crudes or fractions thereof to reduce or eliminate their acidity and corrosivity by addition of suitable amounts of Group IA or Group IIA oxides, hydroxides and hydrates and Group IIA metal naphthenate salts. The process has the additional benefits of reducing materials handling problems associated with treating acidic crude oils using liquid solvents and in reducing emulsion formation.
    Type: Grant
    Filed: November 2, 1999
    Date of Patent: January 20, 2004
    Assignee: ExxonMobil Research and Engineering Company
    Inventors: Saul Charles Blum, Guido Sartori, David William Savage, Martin Leo Gorbaty, Bruce Henry Ballinger, Michael Paul Anderson, Trikur Anantharaman Ramanarayanan, David J. Martella
  • Publication number: 20030144290
    Abstract: Substituted 2-cyclohexyl-4-phenyl-1H-imidazole derivatives capable of modulating NPY5 receptor activity, are provided. Such compounds may be used to modulate NPY binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
    Type: Application
    Filed: October 21, 2002
    Publication date: July 31, 2003
    Applicant: NEUROGEN CORPORATION
    Inventors: Charles A. Blum, Harry L. Brielmann, Stephane De Lombaert, Xiaozhang Zheng
  • Patent number: 6593278
    Abstract: The present invention relates to a method for inhibiting corrosion of corrosion-prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of certain sulfur and phosphorus-free aromatic compounds substituted with nitrogen, containing functional groups at the 5- or 3, 5-position, typically up to 1000 wppm, to the metal surface.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: July 15, 2003
    Assignee: ExxonMobil Research and Engineering Company
    Inventors: Mohsen S. Yeganeh, Shawn Michael Dougal, Guido Sartori, David Craig Dalrymple, Cheayao Zhang, Saul Charles Blum, Liza Marie Monette
  • Patent number: 6583091
    Abstract: The present invention relates to a method for inhibiting high temperature corrosion of corrosion prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of 4-sulfophthalic acid, typically up to 1000 wppm, to the metal surface.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: June 24, 2003
    Assignee: ExxonMobil Research and Engineering Company
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh, Andreas Vogel
  • Patent number: 6566367
    Abstract: Substituted spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: May 20, 2003
    Assignees: Pfizer Inc., Neurogen Corporation
    Inventors: Rajagopal Bakthavatchalam, Charles A. Blum, Harry L. Brielmann, James William Darrow, Stéphane De Lombaert, Alan Hutchison, Jennifer Tran, Xiaozhang Zheng, Richard Louis Elliott, Marlys Hammond
  • Patent number: 6559104
    Abstract: The present invention relates to a method for inhibiting high temperature corrosion of corrosion prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of an additive aromatic compound tri-substituted with acidic functionalities selected from 5-hydroxyisophthalic acid and 1,3,5-benzenetricarboxylic acid, typically up to 1000 wppm, to the metal surface.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: May 6, 2003
    Assignee: ExxonMobil Research and Engineering Co.
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh, Andreas Vogel
  • Publication number: 20030069246
    Abstract: Disclosed are compounds of the formula: 1
    Type: Application
    Filed: February 25, 2002
    Publication date: April 10, 2003
    Applicant: Neurogen Corporation
    Inventors: James W. Darrow, Stephane J. De Lombaert, Charles A. Blum, Jennifer N. Tran, Mark A. Giangiordano, David Andrew Griffith, Philip Albert Carpino
  • Patent number: 6537950
    Abstract: The present invention relates to a method for inhibiting high temperature corrosion of corrosion prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of triphenylstibine, typically up to 1000 wppm, to the metal surface.
    Type: Grant
    Filed: July 13, 2001
    Date of Patent: March 25, 2003
    Assignee: ExxonMobil Research and Engineering Co.
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh
  • Publication number: 20030036652
    Abstract: Substituted spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines capable of modulating NPY5 receptor activity are provided. Such compounds may be used to modulate ligand binding to NPY5 receptors in vivo or in vitro, and are particularly useful in the treatment of a variety of disorders (e.g., eating disorders such as obesity or bulimia, psychiatric disorders, diabetes and cardiovascular disorders such as hypertension) in humans, domesticated companion animals and livestock animals. Pharmaceutical compositions and methods for treating such disorders are provided, as are methods for using such compounds for detecting NPY5 receptors.
    Type: Application
    Filed: December 11, 2001
    Publication date: February 20, 2003
    Applicant: NEUROGEN CORPORATION
    Inventors: Rajagopal Bakthavatchalam, Charles A. Blum, Harry L. Brielmann, James William Darrow, Stephane De Lombaert, Alan Hutchison, Jennifer Tran, Xiaozhang Zheng, Richard Louis Elliott, Marlys Hammond
  • Patent number: 6515133
    Abstract: Certain diaryl imidazoles act as partial agonists or antagonists for NPY receptors, in particular NPY 5 receptors. They are of use, for example in treating loss of appetite. Such compounds bear aryl groups in the 2 position. Many of the compounds are novel.
    Type: Grant
    Filed: March 10, 2000
    Date of Patent: February 4, 2003
    Assignees: Neurogen Corporation, Pfizer, Inc.
    Inventors: Andrew Thurkauf, Jun Yuan, Alan Hutchison, Charles A. Blum, Richard L. Elliott, Marlys Hammond
  • Publication number: 20030012682
    Abstract: The present invention relates to a method for inhibiting high temperature corrosion of corrosion prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of triphenylstibine, typically up to 1000 wppm, to the metal surface.
    Type: Application
    Filed: July 13, 2001
    Publication date: January 16, 2003
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh
  • Publication number: 20030012681
    Abstract: The present invention relates to a method for inhibiting corrosion of corrosion-prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of certain sulfur and phosphorus-free aromatic compounds substituted with nitrogen, containing functional groups at the 5- or 3, 5-position, typically up to 1000 wppm, to the metal surface.
    Type: Application
    Filed: July 13, 2001
    Publication date: January 16, 2003
    Inventors: Mohsen S. Yeganeh, Shawn Michael Dougal, Guido Sartori, David Craig Dalrymple, Cheayao Zhang, Saul Charles Blum, Liza Marie Monette
  • Publication number: 20030013621
    Abstract: The present invention relates to a method for inhibiting high temperature corrosion of corrosion prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of an additive aromatic compound tri-substituted with acidic functionalities selected from 5-hydroxyisophthalic acid and 1,3,5-benzenetricarboxylic acid, typically up to 1000 wppm, to the metal surface.
    Type: Application
    Filed: July 13, 2001
    Publication date: January 16, 2003
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh, Andreas Vogel
  • Publication number: 20030012684
    Abstract: The present invention relates to a method for inhibiting high temperature corrosion of corrosion prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of 4-sulfophthalic acid, typically up to 1000 wppm, to the metal surface.
    Type: Application
    Filed: July 13, 2001
    Publication date: January 16, 2003
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh, Andreas Vogel
  • Publication number: 20030012683
    Abstract: The present invention relates to a method for inhibiting high temperature of corrosion-prone metal surfaces by organic acid-containing petroleum streams by providing an effective corrosion-inhibiting amount of phosphorous acid, typically up to 1000 wppm, to the metal surface.
    Type: Application
    Filed: July 13, 2001
    Publication date: January 16, 2003
    Inventors: Guido Sartori, David Craig Dalrymple, Saul Charles Blum, Liza Marie Monette, Mohsen S. Yeganeh, Andreas Vogel
  • Patent number: 6476038
    Abstract: Disclosed are compounds of the formula: where R1, R2, R3, R4, R5, R6, and X are defined herein. These compounds are selective modulators of NPY1 receptors. These compounds are useful in the treatment of a number of CNS disorders, metabolic disorders, and peripheral disorders, particularly eating disorders and hypertension. Methods of treatment of such disorders and well as packaged pharmaceutical compositions are also provided. Compounds of the invention are also useful as probes for the localization of NPY1 receptors and as standards in assays for NPY1 receptor binding. Methods of using the compounds in receptor localization studies are given.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: November 5, 2002
    Assignees: Neurogen Corporation, Pfizer Inc.
    Inventors: James W. Darrow, Stéphane De Lombaert, Charles Blum, Jennifer Tran, Mark Giangiordano, David Andrew Griffith, Philip Albert Carpino